NGS for germline CNVs pilot
EQA for quality of NGS for CNVs >50bp (Germline DNA). For whole exome or genome sequencing. Pilot EQA Scheme.
Breast Cancer (ESR1 and PIK3CA cfDNA Testing) [Plasma]
ESR1 and PIK3CA testing in cfDNA (plasma) for metastatic breast cancer. This EQA is sponsored.
Comprehensive Genomic Profiling (CGP)
Identification of different types of variants and genomic signatures by CGP in solid tumour (FFPE). This is a pilot EQA (genotyping only), places are limited, complete the form to express interest in participation (see participant information section).
Urothelial/bladder cancer (FGFR SNV/fusions) [Tissue]
FGFR3 testing (SNVs and gene fusions) in Urothelial / Bladder cancer (FFPE)
Pan-Tumour Fusions [FFPE]
Fusion gene testing for fusions relevant to therapy (ALK, ROS1, RET, NTRK1, NTRK2, NTRK3, FGFR1, FGFR2, or FGFR3) for solid cancers (FFPE)
Homologous Recombination Deficiency (HRD) testing in ovarian cancer [Tissue]
HRD testing for Ovarian Cancer (Tissue). This EQA is sponsored.